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In nature, organisms are commonly infected by an assemblage of different parasite
species or by genetically distinct parasite strains that interact in complex ways. Linked
to co-infections, pathocoenosis, a term proposed by M. Grmek in 1969, refers to a
pathological state arising from the interactions of diseases within a population and to
the temporal and spatial dynamics of all of the diseases. In the long run, malaria was
certainly one of the most important component of past pathocoenoses. Today this
disease, which affects hundreds of millions of individuals and results in approximately
one million deaths each year, is always highly endemic in over 20% of the world and
is thus co-endemic with many other diseases. Therefore, the incidences of co-infections
and possible direct and indirect interactions with Plasmodium parasites are very high. Both
positive and negative interactions between malaria and other diseases caused by parasites
belonging to numerous taxa have been described and in some cases, malaria may modify
the process of another disease without being affected itself. Interactions include those
observed during voluntary malarial infections intended to cure neuro-syphilis or during the
enhanced activations of bacterial gastro-intestinal diseases and HIV infections. Complex
relationships with multiple effects should also be considered, such as those observed
during helminth infections. Moreover, reports dating back over 2000 years suggested
that co- and multiple infections have generally deleterious consequences and analyses
of historical texts indicated that malaria might exacerbate both plague and cholera, among
other diseases. Possible biases affecting the research of etiological agents caused by the
protean manifestations of malaria are discussed. A better understanding of the manner
by which pathogens, particularly Plasmodium, modulate immune responses is particularly
important for the diagnosis, cure, and control of diseases in human populations.
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INTRODUCTION
More than 1400 parasite species, including viruses, bacteria,
fungi, protozoa and helminths, infect humans (Taylor et al.,
2001), and the simultaneous presence of multiple species or of
multiple strains of the same species (co-infection) in the human
body is commonplace (Cox, 2001; Brogden et al., 2005; Balmer
and Tanner, 2011). Therefore, it is likely that the true preva-
lence of co-infection exceeds one sixth of the global population
(Griffiths et al., 2011). Because interactions among co-infecting
parasites, which are also termed poly- or multi-parasitisms, can
affect host pathology, parasite transmission, and virulence evolu-
tion, this phenomenon is of great interest to biomedical research
(Rigaud et al., 2010); furthermore, it may lead to biases in the
analyses of clinical studies because most co-infections possess
associated comorbidities.
Historically, malaria was probably one the diseases with the
greatest opportunity to interact with other diseases because of
the extent of the malarious areas, of the level of endemicity and
of the fact that humans could be infected during all the dura-
tion of their lives (Sallares, 2005; Faure, 2012, 2014). Moreover,
since Hippocrates and Galen, ancient authors, who were generally
shrewd observers, highlighted the increased risk of co-infections
in individuals with malaria (Sallares, 2002), and it may be par-
ticularly interesting to confront their assumptions with the most
recently reported molecular data.
Despite progress in malaria management, it continues to
impact annually hundreds of millions of people (WHO, 2013)
and therefore, the number of potential co-infections involving
this parasitosis remains very high. The focus of this article is to
underline some aspects of the complexity of the relationships
between malaria, other diseases and the human genome.
MALARIA IS A PROTEAN DISEASE WITH DEVASTATING
CONSEQUENCES ON HUMAN BEINGS
Malaria is an acute and chronic disease caused by obligate intra-
cellular protozoan parasites of the genus Plasmodium, transmitted
through the bite of female Anopheles mosquitoes. Five species of
malaria parasites infect humans (Igweh, 2012): Plasmodium fal-
ciparum causes malignant tertian malaria, P. vivax and P. ovale
(found only in Africa) cause benign tertian malaria, P. malariae
causes benign quartan disease, and P. knowlesi primarily infects
non-human primates. Repeated bouts of tertian or quartan fevers
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are caused by the cyclic release of merozoite parasites from lysed
erythrocytes every 2 or 3 days, respectively (more specifically,
febrile paroxysms occur every third or fourth day, respectively,
counting the day of occurrence as the first day of the cycle) and
commonly result in body temperatures as high as 41◦C; however,
malarial fevers can also be irregular, continuous or low-grade,
as in children or during primary infections and co-infections
(Igweh, 2012). Moreover, concerning P. vivax, the term “benign”
tertian malaria is a misnomer, as this species can cause seri-
ous and fatal illness with severe clinical syndromes, including
comatose cerebral malaria, and acute renal, hepatic and pul-
monary dysfunctions (Baird, 2013). P. vivax risk should be con-
sidered seriously because this species is responsible for approx-
imately 60–80% of all malarial infections worldwide (Leoratti
et al., 2012).
Today, malaria is considered as a tropical disease because of
its prevalence in warm regions, but historically it was present
in all climate zones worldwide; e.g., in Europe, this disease
extended widely from the Mediterranean Basin to the coasts of
the Arctic Sea (Huldén and Huldén, 2009; Faure, 2012; Faure
and Jacquemard, 2014). Malaria was likely the most deadly of
all human diseases, and its impact on humanity has been the
subject of much speculation. Authors have held that its ravages
disrupted the socioeconomic fabric of societies and even led to
the decline and disappearance of civilizations (e.g., Jones, 1907;
McNeill, 1979).
In several areas of the past Afro–Eurasia (and later America),
the levels of malarial endemicity led to the infection of a great
number of humans every year, which may have reduced life
expectancy (Sallares, 2002; Roucaute et al., 2014). Plasmodium
infection during pregnancy strongly increases the risk of neona-
tal mortality, and young children are particularly vulnerable to
malaria (Carter and Mendis, 2002; WHO, 2013). Hundreds of
gene mutations confering a survival advantage against malaria
are known (Patrinos et al., 2004). Considering the most common
mutations, more than 15% of the world population bears muta-
tions conferring resistance to malaria (Dean, 2005; WHO, 2006;
Cappellini and Fiorelli, 2008). Several of these mutations are
under balancing selections, which maintains deleterious alleles in
a population at a relatively high frequency (Barton and Keightley,
2002). For example, sickle-cell gene mutations are well-known
examples of balancing selection. In this case, the heterozygote has
a higher fitness than both the mutant and the normal homozy-
gote. This seems to indicate that P. falciparum was so deadly that
it is better to risk a 25% probability of a dead child (homozygous
for the sickle-cell gene) than to forsake the possibility of a way to
fight against the parasite, and shows evidence of the high level of
endemicity and continual selection pressure exerted by malaria in
the past.
During the 19th century, over half of the world’s population
was at significant risk of contracting malaria, and out of those
individuals directly affected by this disease, at least 1 in 10 could
expect to die (Carter and Mendis, 2002) despite the use of qui-
nine in several countries. Malaria is nowadays still the dominant
infectious disease in regions of Sub-Saharan Africa and South
Asia (WHO, 2013). Despite concerted efforts to reduce its dele-
terious impacts, the estimated cases and deaths in 2012 were
approximately 607 million and 627,000, respectively. Moreover,
the number of deaths may be greatly underestimated and could
likely be doubled (Murray et al., 2012). Because malaria is
endemic in over one third of the world, with 3.3 billion people
at risk of infection (WHO, 2013), the risk of deleterious co-
infections with other pathogens is high. Some of these pathogens
are major overlooked tropical diseases, but the most prevalent co-
infections involve HIV/AIDS, tuberculosis and/or helminthiases
(Troye-Blomberg and Berzins, 2008).
Malaria is a protean disease: its clinical manifestations and
symptoms can be quite diverse and may be similar to other
disease entities. Protean clinical manifestations of malaria are
known since at least the 17th century (Morton, 1692). Moreover,
Plasmodium infections can also produce different results with dif-
ferent biocoenoses (Roucaute et al., 2014). This has major impli-
cations in the search for the causative agent(s) of the observed
clinical manifestations. Single infections can be misdiagnosed,
co-infections can be falsely suspected, or, contrarily, one of the
organisms involved in a true co-infection may remain unsus-
pected. For example, severe multiorgan disorders affecting, lung,
heart, liver, spleen, kidney, and intestines are associated with
P. falciparum, as well as with other species such as P. vivax (Baird,
2013). Among these manifestations, gastro-intestinal symptoms
are predominant, and brain damage and respiratory disorders
are common (Sallares, 2002). Many case reports have also been
published regarding association of P. falciparum malaria and
symmetrical peripheral gangrene (Agrawal et al., 2014), which
is a symptom that has been observed during typhus epidemics
(Rickettsia prowazekii). Misdiagnoses with other diseases with
similar signs and symptoms are frequent: diseases with non-
specific periodic fever such as gastroenteritis, typhoid fever, hep-
atitis A, influenza, pneumonia or bacterial meningitis have been
diagnosed although the implication of malarial infections alone
were subsequently validated (e.g., Mehndiratta et al., 2013; Nayak
et al., 2013). Misdiagnosed patients frequently responded well to
treatment with cinchona (or quinine since the 1820s), evidenc-
ing the implication of malaria (Roucaute et al., 2014). Contrarily,
in endemic areas, other diseases might also be misdiagnosed as
malaria (e.g., Källander et al., 2008).
IN THE ANCIENT WORLD, MALARIA WAS LIKELY THE MOST
IMPORTANT COMPONENT OF PATHOCOENOSES
The concept of pathocoenosis was introduced by Grmek (1969,
1991), who proposed to consider diseases of a given host pop-
ulation as a whole, thereby integrating both historical and geo-
graphical dimensions. Grmek defined pathocoenosis as follows:
“By pathocoenosis, I mean the qualitatively and quantitatively
defined group of pathological states present in a given popula-
tion at a given time. The frequency and the distribution of each
disease depend not only on endogenous—infectivity, virulence,
route of infection, vector—and ecological factors—climate, urban-
ization, promiscuity—but also on frequency and distribution of
all the other diseases within the same population”. This neolo-
gism was modeled from the term “biocoenosis” which was an
old ecological concept coined by Karl Mobius. The pathocoeno-
sis concept also fits with Braudel’s “longue durée” paradigm
(Arrizabalaga, 2005) even though Grmek particularly insisted on
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the occurrence of ruptures and breaks in pathocoenoses. The
introduction of a new pathogen (such as Plasmodium) would
induce a breakdown in pathocoenosis, causing a shift toward
a supposedly novel state of equilibrium. Indeed, pathocoenoses
are constantly evolving, but these dynamic states are difficult to
comprehend.
Sallares (2005) considered that “where malaria occurred in
antiquity, in the long run it was the singlemost important compo-
nent of the pathocoenosis, or ecological community of pathogens,
not only because of its own direct effects on mortality and mor-
bidity but also because of its synergistic interactions with other
diseases, especially respiratory and intestinal diseases. This com-
bination drastically reduced both life expectancy at birth and
adult life expectancy in areas where malaria was endemic.” While
this is not absolute proof that malaria was the most impor-
tant component of past pathocoenoses (including not only those
of the classical antiquity), strong arguments exist in support of
this hypothesis, suggesting that malaria was the most frequent
fatal disease due to both direct and indirect effects. Several indi-
rect empirical studies support the Grmek’s hypothesis suggesting
that the prevalence of a disease could depend on that of “all
other diseases.” Indeed, in numerous well-documented cases,
effective malaria-specific interventions (e.g., insecticide spraying,
insecticide-impregnated bed-net programs or implementation
of preventive treatments) have lead to reductions in mortal-
ity several-fold greater than would have been expected on the
basis of the estimation of malaria-related mortality (e.g., Shanks
et al., 2008; Dicko et al., 2012). For example, in Guyana, in the
1940–50s, the number of deaths from all causes (including non-
vector transmitted diseases) decreased with deaths from malaria
and followed the elimination of the mosquito vector (Giglioli,
1972). Similarly, in an Italian town in 1925, all of the children
had splenomegaly (enlarged spleen often associated with chronic
malaria), but only a dozen individuals had symptoms of acute
malaria, and only 8% of all deaths were directly attributed to
malaria. After the eradication of malaria in this town, the crude
death rate fell from 41 per 1000 to 20 per 1000 (Sallares, 2002).
It is difficult to quantify the direct and indirect contributions of
malaria to overall mortality, and the interdependence between
various diseases, but the evidences suggest it is highly significant
(see Shanks et al., 2008).
The impacts of infectious agents not only depend on their
associated morbidity but also on the general health of the affected
population.Many epidemics due tomalaria or other diseases have
coincided with periods of famine, affecting underprivileged pop-
ulations (Nájera et al., 1998). Recent literature on the relationship
between malaria and nutrition is controversial; however, nutri-
tional deficiencies are frequent in malaria-endemic areas, and
vitamin intake may play an important role in the proliferation of
the malaria parasite (Nankabirwa et al., 2010; Javeed et al., 2011).
Even if malnutrition and malarial impacts are not directly linked,
their inter-relationship is generally accepted as being synergistic,
with one promoting the other, and a similar synergism is likely to
occur in the development of other diseases (Nájera et al., 1998).
Thus, the consideration of socio-economic determinants likely
does not compromise the analyses of the major implications of
malaria in past pathocoenoses.
The deleterious effects of malaria during co-infections were
primarily hypothesized by Hippocrates (Sallares, 2002) and have
been empirically theorized by physicians during the 18-19th
centuries, principally in France and England (Dobson, 1997;
Roucaute et al., 2014). The physicians’ observations suggested
frequently that malaria was present simultaneously with other
diseases: (1) one disease could replace another, e.g., during epi-
demic peaks, a new disease (such as cholera) could seem to
temporarily replace malaria; (2) most diseases, if they persisted,
took on a periodic form; (3) periodic nature of fevers could
accompany non-epidemic diseases; (4) repeated bouts of malaria
might render individuals more vulnerable to other diseases; and
(5) in malaria-free cities, the health situation was particularly
good and the frequencies of other diseases and epidemics were
relatively low. Current knowledge provides scientific explanations
for these empirical observations; indeed, besides the high rate of
malarial endemicity, there is strong evidence that malaria can lead
to an altered immune response.
THE VERY COMPLEX RELATIONSHIPS BETWEEN IMMUNITY
AND MALARIA
During a co-infection, if one of the two pathogens perturbates
the immune response, the consequences for the host might be
very severe. Numerous studies have shown that malaria pro-
foundly affects the host immune system by mediating both
immunosuppression and immune hyper-activation (e.g., Chêne
et al., 2011; Butler et al., 2013; Pradhan and Ghosh, 2013).
P. falciparum malaria disturbs, among other immune functions,
the specific T-cell response, the induction of regulatory T cells
and cytokine balance and is associated with polyclonal hyper-
immunoglobulinaemia, production of multiple autoantibodies
and suppression of specific antibody responses (Cunnington,
2012). A deregulated balance of the host immune response has
also been observed during P. vivax infection (Leoratti et al., 2012;
Rodrigues-da-Silva et al., 2014). By their distribution, burden
of disease and impact on immune responses, P. falciparum and
to a lesser extent P. vivax are the two Plasmodium species that
have the greatest negative effect on human populations (Leoratti
et al., 2012;Maguire and Baird, 2014). Although severe illness also
occurs with P. malariae and P. ovale, these seem to be relatively
rare events.
Malaria-induced hemolysis impairs also the immune response
via, among other mechanisms, hemozoin produced during heme
detoxification. Hemozoin is a strong modulator of the innate
immune response, and has the potential to be detrimental or
beneficial to the host, most likely depending on the stage of
the infection (Cunnington, 2012; Olivier et al., 2014). Moreover,
malaria infection results in alterations in splenic structure, which
may affect the qualities of antibody responses and may impact the
development of immunity to other infections (reviewed by Del
Portillo et al., 2012). To date, data to determine whether malaria-
induced immunosuppression (“immunomodulation” may be
more appropriate; Cunnington and Riley, 2010) is significant
in the long-term are lacking. Moreover, although acute malaria
infection may impair the immune response, the consequences
of immunological changes due to persistent immune activa-
tion during recurrent or persistent infections are poorly known;
www.frontiersin.org November 2014 | Volume 5 | Article 441 | 3
Faure Malaria: interactions with other diseases
however, both asymptomatic and symptomatic P. falciparum
malarial infections suppress immune responses to heterolo-
gous polysaccharides and sometime protein antigens in vaccines
(Cunnington, 2012). Additionally, antimalarial treatment may
enhance responses to some types of vaccines (Cunnington and
Riley, 2010).While it is still unclear how parasite-induced changes
in the host immune response influence the clinical manifestations
of Plasmodium infections, malaria is associated with poor anti-
body responses to chronic Epstein-Barr viremia and an increase
in HIV viral load and bacteremia (Cunnington and Riley, 2012).
CLINICAL IMPORTANCE OF MALARIA CO-INFECTIONS WITH
OTHER DISEASES
BRIEF TERMINOLOGY OF DISEASE INTERACTIONS
Humans, like other metazoans, are continuously infected by
a very wide variety of agents that may disappear without the
development of clinical signs (Girard et al., 1998). Similarly,
co-infection does not necessarily imply a morbid state, and co-
infection and comorbidity are non-synonymous occurrences. In
this article, the term co-infection refers to two or more species or
strains of parasites that are simultaneously present in a given host,
regardless of the presence of morbid signs. When in doubt, the
use of this word is preferred over that of comorbidity. This latter
term is used in cases in which two or more infectious diseases co-
occur simultaneously in the same individual, indicating that each
infectious agent has caused the clinically evident impairment of
normal functioning.
Infectious agents can interact in various ways (both directly
and indirectly) with each other and with their host. With regard
to ecology in general and the microbial world in particular, one
population can influence a second one in different ways, and these
effects can be positive, negative or neutral (e.g., Wilson, 2009).
However, true neutrality is virtually impossible to prove, and may
be wrongly presumed due to limited knowledge of the relation-
ships between pathogens. Cooperative or interfering interactions
are frequently defined as synergistic or antagonistic (Mayhew,
2006). In antagonistic interactions, one infectious agent benefits
at the expense of another, but one pathogen can negatively inter-
fere with another without deriving cost or benefit; in this case, the
term “amensalism” is more appropriate. Synergism is a mutually
advantageous relationship, commensalism is the term used when
only one of the partners benefits from the other without either
harming or benefiting the latter. The direct interaction of an
infectious agent with another can occur within the same host; but
indirect effects mediated by the host seem to explain most cases
of disease interactions, which principally occur via the immune
system. Thus, the terms “interactions between infectious agents”
and “interactions between infectious diseases” are not equivalent.
During disease co-occurrence, neutral (two or more comorbid
diseases with no apparent interactions), synergistic and antag-
onistic combinations of diseases have been observed (Gonzalez
et al., 2010). However, co-infections may result in overall interac-
tions between conditions that are not necessarily strictly neutral,
synergistic or antagonistic, but that likely represent a continuum
of interactions similar to what occurs between microorganisms.
Because of the lack of specific terms available for describing some
types of disease interactions, the interactions betweenmalaria and
other diseases have been divided into two large groups; those for
which the co-infection negatively affects the other disease, and
those for which the co-infection positively affects the other disease
or results in a synergistic interaction.
EXAMPLES OF TRUE OR SUPPOSED NEGATIVE INTERACTIONS
Malarial fever therapy applied to the treatment of neurological
syphilis
Awell-known example of negative interaction between pathogens
is that between those responsible of malaria and syphilis. From
the early 1920s until the advent of penicillin in the mid 1940s,
a therapeutic strategy using malarial inoculation in the treat-
ment of syphilitic patients with dementia paralytica was used in
Europe and North America (reviewed by Snounou and Pérignon,
2013). The Austrian neuro-psychiatrist Julius Wagner Jauregg
(Nobel Prize in 1927) was considered the initiator of this method.
The inoculation (generally of P. vivax) was performed using
infected blood or more rarely by the bite of infected mosquitoes.
Malaria was cured using quinine only after some fits of fever.
Some patients were effectively cured of syphilis, and many went
into partial remission or observed a halt in the progression of
their symptoms. However, the Hippocratic principle primum non
nocere was not pre-eminent; e.g., some patients with syphilis
who were treated using P. vivax subsequently died, and higher
mortality rates (up to 15%) were observed in individuals with
additional comorbidities (Baird, 2013). The so-called “malaria-
therapy” has greatly contributed to our knowledge of human
malarial infections but our understanding of the effectiveness of
this treatment is recent. The in vivo optimal temperature range
of Treponema pallidum is 33–35◦C, rendering this bacterium sen-
sitive to malaria-induced fever (Snounou and Pérignon, 2013).
However, in co-infected individuals, syphilis can be more rapid in
its course and resistant to treatment in proportion to the chronic-
ity of the malarial infection; moreover, malarial infection might
arouse latent syphilis (Deaderick, 1909). Molecular studies have
revealed that this could be due to synergistic effects inducing
CD4+ suppression in individuals with both malaria and syphilis
(Wiwanitkit, 2007). Experimental studies and observations from
around a century ago suggest that malarial fevers accelerate recov-
ery from another venereal disease, the gonorrhea, caused by the
bacterium Neisseria gonorrhoeae, which is also very sensitive to
temperature; a temperature increase of only a few degrees kills
these pathogens (Anonymous, 1929; Simpson, 1936).
Malaria and tuberculosis
Until the 19th century, it was believed that tuberculosis (pul-
monary phthisis) was rare or absent in highly malarial endemic
areas because of an antagonism between tuberculosis and inter-
mittent fevers (Bidlot, 1868). However, more recent data con-
tradict this hypothesis. Experiments using murine in vitro and
in vivo models have demonstrated a bi-directional effect: malaria
exacerbates Mycobacterium tuberculosis infections, whereas this
pathogen modulates the host response to malaria (Hawkes et al.,
2010; reviewed by Li and Zhou, 2013). Immune dysregulation,
lung pathology and hemozoin loading of macrophages in the con-
text of acute malarial infection led to increased mycobacterial
loads (Mueller et al., 2012).
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Malaria and helminthiases
Helminthiases affect over 800million people worldwide (Griffiths
et al., 2014), and there is significant geographical overlap between
these parasites and Plasmodium and co-infections are numerous:
malaria co-occurs with 80–90% of all soil-transmitted helminth
cases worldwide (WHO, 2011). To date, there is still no clear pic-
ture of the impact of intestinal worms on malaria and vice versa
(Adegnika and Kremsner, 2012; McSorley and Maizels, 2012).
Ascaris and platyhelminths may be protective against malarial
infection and severe manifestations, whereas hookworms seem to
increase malarial incidence (Nacher, 2011; Lemaitre et al., 2014).
Interestingly, inmurinemodels of malaria-helminth co-infection,
cross-reactive antibody responses have been observed, in which
antigens from both pathogens are recognized. Moreover, co-
infection with Plasmodium and schistosome parasites, which are
phylogenetically distinct from helminths, leads to similar results.
These cross-reactivities may be relevant in other co-infection sys-
tems and warrant further attention because of their potential
influences on disease outcomes (Fairlie-Clarke et al., 2010 and
references therein). True synchronous co-infections are relatively
rare, they may result from the ingestion of contaminated food
or drinking water or tick bites and principally concern bacterial
and viral infections (Lantos and Wormser, 2014). With regard
to malaria, the mosquito-borne parasitic nematode Wuchereria
bancrofti, which causes lymphatic filariasis, can be transmit-
ted by the common Anopheles malaria vector species in many
tropical regions. Thus, this disease and malaria may not occur
independently, and the risk of co-infection (excluding the poten-
tial risk for co-infectious complications resulting from blood
transfusions) may be considerable (Manguin et al., 2010).
Malaria and hepatitis B virus (HBV) infection
Several malaria-endemic areas are also highly endemic for HBV
infection (Andrade et al., 2011). Furthermore, Plasmodium and
HBV may utilize common receptors during hepatocyte inva-
sion, suggesting possible interactions at both immunological
and cellular levels during co-infections (Freimanis et al., 2012).
However, currently, there is no clear consensus regarding whether
Plasmodium affects HBV infection and vice versa. Studies have
found conflicting results: each infection appears to evolve inde-
pendently, but the cross-reactive immune response affects both
pathogens. Acute P. falciparum malaria can modulate viremia
in patients with chronic HBV infection, whereas the latter can
diminish the intensity of malarial infection (Freimanis et al.,
2012). It is likely that the type of interaction would depend on
the HBV genotype, the Plasmodium strain or species and the
immunological response to malarial and viral infections (from
asymptomatic to acute).
POSITIVE AND SYNERGISTIC INTERACTIONS
Negative interactions between diseases appear to be rare; much
more frequently, pathogens take advantage of an immune sys-
tem that has been compromised by other infections such as AIDS
(Gonzalez et al., 2010).
Relationships with virus
HIV. According to a WHO report, there were 35.3 million indi-
viduals living with HIV infections in 2012, and in the same year,
1.6 million individuals died of AIDS (UNAIDS, 2013). Moreover,
as millions of HIV-infected individuals live in malaria-endemic
areas, co-infections are frequent (Cunnington, 2012). Several
studies have suggested that people infected with HIV have more
frequent and more severe episodes of malaria and vice versa. HIV
and Plasmodium both interact with the host’s immune system,
resulting in a complex activation of immune cells leading to dys-
functional levels of antibody and cytokine production (Flateau
et al., 2011; Cunnington and Riley, 2012; Alemu et al., 2013; Berg
et al., 2014; Van Geertruyden, 2014). On the one hand, malaria
has been reported to increase HIV replication in vitro and in
vivo, and studies using murine models suggest that malarial infec-
tion enhances the sexual acquisition of HIV due to, among other
factors, the upregulation of HIV co-receptor expression (Chege
et al., 2014). On the other hand, HIV infects and destroys CD4+
T helper cells, which are responsible for the specific immune
response. As the infection progresses, patients become more
vulnerable to other infections, including malaria. HIV-positive
individuals suffer higher malarial parasitemia and worse clinical
outcomes. Patients with HIV and malaria co-infection had signif-
icantly more frequent respiratory distress, liver and renal failure
than patients with malaria alone (Berg et al., 2014); however, the
mechanisms underlying these disease interactions remain unclear
and require further investigation (e.g., HIV infection particu-
larly increases the incidence and severity of malarial infection
in areas of low malarial transmission Frosch and John, 2012).
Moreover, the combinations of antiretroviral and antimalarial
therapies could have possible synergistic or antagonistic effects on
treatment efficacies and toxicities (Van Geertruyden, 2014). For
example, the use of anti-malarial therapy for patients with HIV
co-infection is less effective compared to its use in patients with
only malaria. Interestingly, anti-HIV drugs have known activities
against parasites during the liver stage and asexual blood stage
(Hobbs et al., 2013).
Herpesvirus. Epstein–Barr virus (EBV) is a gamma-herpesvirus.
Epstein–Barr virus infection generally has a benign clinical
course; however, this agent is linked to several B-cell (principal
target cell) malignancies, including endemic Burkitt’s lymphoma
(eBL), especially in immunosuppressed hosts (Chêne et al., 2011).
Endemic-BL, which is one of the most prevalent pediatric can-
cers in equatorial Africa and Papua New Guinea, occurs at high
incidence in populations where P. falciparum malaria is holoen-
demic (Chattopadhyay et al., 2013; Mulama et al., 2014), and
anti-malarial treatment in a holoendemic area has been linked to
a decrease in eBL incidence (Chêne et al., 2011). Although the
causal association between EBV and eBL has been established, the
precise mechanisms of P. falciparum’s involvement in lymphoma-
genesis remain unclear. Malarial infection has been associated
with both immunosuppression and immunoactivation, leading
to B-cell proliferation and an increase in peripheral-blood EBV
loads (references in Mulama et al., 2014); however, the incidence
of eBL is low relative to the high prevalence of both malaria and
EBVwithin the pediatric populations, suggesting the involvement
of additional factors in its etiology. This could be correlated to the
following observations: long-term malarial infection may be pro-
tective (Chêne et al., 2011) and sickle-cell trait does not confer
protection against eBL (Mulama et al., 2014).
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Epstein-Barr virus is one of the eight human herpesviruses
known to date. These viruses are widely distributed. In immuno-
competent hosts, the clinical outcomes are generally benign,
whereas in immunodeficient individuals, primary infection or
viral reactivation can lead to severe diseases such as meningitis,
encephalitis and pneumonitis and to the development of malig-
nancies (Chêne et al., 2011). The replication of some but not all
herpesvirus species may also be favored by episodes of malaria
(Chêne et al., 2011). Acute P. falciparum malarial infection may
induce herpes simplex labialis and varicella-zoster virus reacti-
vation (Chêne et al., 2011 and references therein). Moreover,
recently, a syndemic relationship between Kaposi’s sarcoma (KS)
and P. falciparum malaria has been hypothesized (Conant et al.,
2013) based, among other factors, on the co-incidence of aggres-
sive forms of KS in malaria-endemic regions. Kaposi-sarcoma-
associated herpesvirus is necessary but not sufficient to cause
KS, and this sarcoma is more common in HIV-co-infected peo-
ple who have developed immunodeficiency. However, during
latency, gamma-herpesvirus may protect mice against malaria,
whereas during acute infection, both the morbidity and mor-
tality of malarial infection were significantly enhanced (Haque
et al., 2004). It has also been speculated that through the down-
regulation of the cytokine cascade, EBV might reduce the most
severe effects of malaria in children in Africa (Watier et al.,
1993).
Flaviviruses. Thanks to vaccinations against yellow-fever virus,
co-infections with this virus and Plasmodium, which lead to
severe health consequences, have virtually disappeared (Wade
et al., 2010). Today, dengue fever (also caused by a flavivirus)
and malaria are the two most common arthropod-borne diseases
and are widespread in American and Asian intertropical regions,
where their endemic areas greatly overlap; however, co-infections
are considered to be relatively rare (Yong et al., 2012). Conflicting
reports exist on whether dengue-malaria co-infection is more
severe than either infection alone (Yong et al., 2012), and malaria
and dengue infections share many similar clinical manifestations,
which may delay diagnosis and may thus be fatal for co-infected
patients (Assir et al., 2014).
Viruses causing “winter respiratory diseases.” Some symptoms
are similar for malaria and “winter respiratory diseases,” such
as pneumonia and influenza, and malaria deleteriously interacts
with these diseases (Sallares, 2002; Hawkes, 2012 for pulmonary
manifestations of malaria). For example, in several areas dur-
ing the period 1918–1920, the “Spanish” influenza pandemic
more severely affected malaria-infected individuals and, nowa-
days, co-infections with influenza are frequently associated with
longer hospitalization times than single infections (Afkhami,
2003; Shanks and White, 2013). However, influenza could not
exacerbate P. vivax malaria contrarily to P. falciparum malaria
(Shanks and White, 2013).
Smallpox virus. Although the data can be contradictory, relation-
ships between smallpox and malaria are probable and perhaps
more complex than expected. Indeed, a century ago, it was noted
that in co-infected individuals, plasmodia could disappear from
the blood with the onset of the smallpox. Moreover, mortality in
these cases was unusually high (Deaderick, 1909).
Relationships with bacteria
Data from the pre-antibiotic era suggest that malaria increases
the host’s susceptibility to invasive bacterial infections, e.g., it was
observed that malaria was often associated with these diseases,
even in countries where they were rare in healthy individuals.
Moreover, in co-infected individuals, cures using quinine were
able to spontaneously clear bacterial infections without addi-
tional treatment (Sallares, 2002, 2005; Cunnington, 2012). More
recently, a study has shown that in Kenyan children, sickle-cell
trait was associated with a strong decreased risk of bacteremia,
suggesting that approximately two-thirds of bacteremia cases
were attributable to the effect of malaria (Scott et al., 2011).
Malaria may cause susceptibility to bacteremia through, among
other factors, impairment of phagocytic cell function, immuno-
paresis, complement consumption, or hemolysis (which may
cause neutrophil dysfunction) (Berkley et al., 2009; Cunnington,
2012; Chau et al., 2013). The exacerbation of bacterial infections
has been observed during acute malaria, but also when the par-
asitemia density was very low and during severe anemia, which
generally occurs following prolonged or recurrent malarial infec-
tions (Cunnington, 2012). According to this last author, these
observations might be reconciled by postulating that malaria
causes susceptibility to bacteria through a delayed mechanism
following onset of either parasitemia or symptoms.
Relationships with bacteria inducing gastro-intestinal
disorders. The geographical and seasonal (generally during
the hottest months of the year in temperate areas) correlations
between malaria and gastro-intestinal diseases have been men-
tioned by past physicians (e.g., Aiton, 1832; Marchiafava and
Bignami, 1894). Later, it was demonstrated that bacterial enteric
pathogens such as Vibrio cholerae, Shigella spp., and Salmonella
spp. cause most cases of severe acute diarrhea. Clinical signs
frequently excluded malaria as a diagnosis, even if P. falciparum
and P. vivax can cause gastro-intestinal symptoms similar to
those of typhoid fever or dysentery (e.g., Sallares, 2002; Singh
et al., 2011; Naha et al., 2012). On the other hand, malaria
can exacerbate the effects of bacterial gastro-intestinal diseases,
while the characteristic intermittent fits of fever may be masked
by the continue fever due to bacterial infections. In addition
to the mechanisms mentioned above, malaria may critically
enhance the susceptibility to intestinal bacteria by increasing gut
permeability (Cunnington, 2012).
Associations between typhoidal and/or non-typhoidal
salmonelloses and malaria have been reported frequently in
patients with severe complications, in which synergistic inter-
actions have been observed (Sallares, 2002; Pradhan, 2011;
Bhattacharya et al., 2013; Shanks and White, 2013). Although
typhoid fever (caused by Salmonella enterica serotype Typhi) and
malaria have different etiologies, some of their clinical features
overlap, including hepatic, pneumonial, encephalopathic and
gastro-intestinal disorders (Smith, 1982). Moreover, attacks
caused by P. falciparum may take the form of (sub)continuous
fevers, which are typical of enteric infections (Pradhan, 2011).
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In malarial endemic areas, due to the difficulty of differentiating
typhoid fever from malaria, physicians of the 19th century used
the term “typho-malaria” when either was suspected (Smith,
1982). This could be an argument against the hypothesis of
malaria major role in past pathocoenoses.
The high frequency of mutations in the CFTR gene in
European populations and individuals of European descent could
be an argument against the dominant role of malaria in the
past pathocoenoses. Indeed, mutations in this gene (particularly
the F508 deletion), which cause cystic fibrosis in homozygotes,
could led to a survival advantage following infections of typhoid,
but also secretory diarrhea (including cholera) and tuberculosis
in heterozygotes (Poolman and Galvani, 2007). However, typhoid
fevers predominately occured in South Asia and Sub-Saharan
Africa, and, in temperate areas, cases of typhoid fever were usu-
ally observed during the summer months, whereas malaria might
affect individuals throughout the year due to relapses. Cholera is
also not a likely candidate for the selection of the CFTR F508
mutation because it has probably not been present in Europe
before the 1830s. Due to the correlation between the CFTRF508
mutation frequency and the geographic and historical incidences
of tuberculosis, Poolman and Galvani (2007) suggested that the
putative selective agent for the mutation was a mycobacterium.
Indeed, tuberculosis was a very deadly disease to the first half of
the twentieth century. However, in past Europe, most of the pop-
ulation was rural, and their repeated contacts with environmental
mycobacteria might have provided cross-protection against other
Mycobacterium spp., including those inducing tuberculosis (Silva
and Lowrie, 1994). Hence, the selective agent(s) for the high fre-
quency of CFTR mutations still remain unclear, but does not
contradict the hypothesis of malaria major role in past patho-
coenoses.
During the 19th century, links were established between
cholera and malaria. For example, during the cholera epidemy in
Bengal in 1817–1819, it was noted, “It appeared that the villages
in which it raged most extensively were considered by the natives as
comparatively unhealthy and obnoxious to fevers of the intermittent
type” (Farr, 1852). Similarly, since the second cholera pandemic
(1832–1837), which raged in several areas of Europe and espe-
cially in malarial endemic regions, various authors have suggested
a relationship between these two diseases (Vanoye, 1854). In Turin
(Italy), cholera began in the neighborhoods where intermittent
fevers, especially pernicious fevers, dominated almost every year
(Berutti et al., 1835). In Arles (France), a physician mentioned
that cholera seemed to have replaced the pernicious intermittent
fevers that had previously occurred all year at the same time and
none had appeared during the epidemic year (Guyon, 1832). In
France, the towns or areas where cholera had the most impact
were most often those where malaria was endemic (Dubreuil
and Rech, 1836; Fourcault, 1850). Even if malaria is not a “true
water-borne disease” (such as an infection by bacterially contam-
inated drinking water), in some areas, a parallel can be drawn
between the ecological conditions in which cholera vibrios thrive
and those that favor malarial vector expansion. For example,
in the 1830s, a physician observed that individuals residing in
the regions of towns at the highest altitudes were much health-
ier than those living in lower-elevation neighborhoods in terms
of malarial impacts and cholera epidemics intensities (Roucaute
et al., 2014). An additional report highlighted the surprising fact
that during the cholera epidemic of 1832 in southern France,
laborers who worked in marshy areas did not contract this dis-
ease although they were provided with housing accommodations
which caused them to be in close daily contact with sick and dying
individuals (Guyon, 1832). This may suggest that acquired immu-
nity against malaria may also confer indirect protection against
cholera. Another more plausible hypothesis could be that the
cholera symptoms were caused by Plasmodium (P. vivax in this
case) and not by Vibrio. Indeed, it is also known that cholera
symptoms can be caused by Plasmodium and not by Vibrio, as
observed in a malarious area of Italy where autopsies revealed
high levels of P. falciparum parasites in the blood vessels of the
mucous membranes of the stomach and the small intestine, with
relatively few parasites in the rest of the body (Sallares, 2002).
Putative relationships between malaria and plague. In 1843,
Boudin presented a list of arguments showing potential relation-
ships between plague and malaria: (1) plague epidemics are often
preceded, followed and even accompanied by intermittent fevers;
(2) the highly malarious areas were often those where plague was
endemic [ancient authors believed that plague had a miasmatic
origin]; (3) the most favorable seasons for plague transmission
were those in which malarial fevers were the most numerous and
severe; (4) climatic conditions that ended episodes of intermit-
tent fevers had the same effect on plague; (5) drying of marshes in
areas where severe intermittent fevers were common also resulted
in the disappearance of plague; and (6) the rise in altitude that
strongly reduced the number and severity of intermittent fevers
had a similar influence on plague. More recently, Sallares (2006)
argued “that it is illuminating to keep diseases such as typhus
and malaria constantly in mind when considering the evidence for
historical plague epidemics.”
As for many other diseases, the use of cinchona barks, and
later, quinine, helped to cure some patients suffering from
bubonic plague (e.g., Chicoyneau and Sénac, 1744). These results
suggest a comorbidity involving malaria and further suggest that
the attenuation of the latter disease allowed the cure of some
sufferers; however, this element must always be considered with
caution because the drugs could not be administered at the proper
time and counterfeit drugs were common (Roucaute et al., 2014).
Most of the mentions of malaria and plague comorbidities con-
cerned the Balkans, Western Asia and Africa (e.g., Prus, 1846);
however, intermittent fevers raged in several areas of Europe and
might have been prevalent during plague epidemics, even if char-
acteristic fits of fever might have been masked. For example,
in London from 1661 to 1664, intermittent fevers “raged like a
plague.” These fevers were followed by the true plague of 1665
and 1666, suggesting that co-infections were present at least at
the beginning of the epidemic (Parkin, 1873). Similarly, in Italy
in 1528 and in the area of Marseille, France in 1720–1722, inter-
mittent fevers accompanied plague epidemics (Chicoyneau and
Sénac, 1744; Gardane, 1777; Guyon, 1855). Plague was sometimes
misdiagnosed as malaria; for example, a physician of the 19th
century considered that “the mildest form of plague resembles inter-
mittent fever so much, that it was almost impossible to distinguish
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the disease, before the appearance of buboes” (Parkin, 1873), and
even in the late 20th century, at the beginning of the infection,
cases of true plague could be misdiagnosed as malaria (Sallares,
2006).
The true plague is caused by Yersinia pestis, and analyses of
ancient DNA suggest that this bacterium was the causal agent of
the three human plague pandemics (during the 6–8th, 14–17th
and 19–20th centuries) even if the strains may have varied
(Wagner et al., 2014). Discrepancies between at least the sec-
ond pandemic and both modern bubonic or pneumonic plague
outbreaks have been noted, pertaining to, among other fac-
tors, symptomatic descriptions, infectivity and lethality, epidemic
velocity, and peak seasonality of mortality (Welford and Bossak,
2009). Comorbidities may explain these discrepancies, includ-
ing the seasonal inversion. In modern epidemics, the peaks are
generally observed in winter; in contrast, in medieval Europe,
the plague mortality peaks usually occurred from the late sum-
mer through early fall (Welford and Bossak, 2009). Reports on
the possible relationship between malaria and plague are too
numerous to discuss here. I suggest that in many areas, malarial
endemicity could explain some of the particular characteristics of
past plague epidemics. Epidemics of plague had also severe conse-
quences in malaria-free areas, suggesting that those plague bacilli
were particularly pathogenic or that the populations were highly
sensitive, due, among other factors, to co-infections with agents
with effects analogous to those of Plasmodium.
DISCUSSION
Co-infection is the rule rather than the exception in nature,
and has been documented across diverse systems (Rigaud et al.,
2010). However, our understanding of the manner by which mul-
tiple infections affect their hosts remains limited, and studies
of malaria co-infections could be particularly beneficial. Indeed,
this disease, which was likely one of the most important com-
ponent of historical pathocoenoses, is still a predominant cause
of morbidity and mortality worldwide. Moreover, given the high
prevalence of malaria exposure in endemic zones and the fre-
quent chronic nature of infection, the risks of comorbidities with
other endemic chronic and acute diseases are very high. Malaria,
exemplifying the concept of the pathocoenosis, can interact with
numerous viral, bacterial and eukaryotic taxa across all major
pathogen groups (e.g., Cox, 2001; Sallares, 2005; Cunnington,
2012; Gonçalves et al., 2014). Interest in co-infections involving
malaria has increased in recent years (reviewed in Cunnington,
2012; Gonçalves et al., 2014). Most studies consider cases in which
both diseases seem to be exacerbated, suggesting synergistic inter-
actions, but other types of relationships have been observed. For
example, co-infection does not appear to affect the outcome of
malarial infection, while the other diseases can be either aggra-
vated or slowed. Despite the abundant evidence that malaria and
other diseases interact, the subtlety and complexity of these inter-
actions at the clinical and immunological levels are far from
clear. A better understanding of the manner by which multiple
pathogens modulate the immune response is particularly needed,
and may illuminate novel approaches for the diagnosis, cure and
control of diseases in human populations (Graham et al., 2007).
The complex cytokine balance during co-infections involving
Plasmodium has been summarized in a recent review (Gonçalves
et al., 2014). Although the diverse direct and indirect mechanisms
are not well-understood, Plasmodium may substantially modify
the immune response and even induce an immunosuppression-
like state, which may complicate the clinical outcome of diseases
(Scott et al., 2011; Cunnington, 2012; Sandlund et al., 2013; van
Santen et al., 2013). Even supposedly benign malaria (e.g., due
to P. vivax) may be debilitating, and individuals suffering from
repeated attacks of malaria may be less able to resist other infec-
tions (Dobson, 1997; Sallares, 2002). Conversely, malaria can also
have deleterious effects on the survival of some infectious agents,
possibly as a result of the immunomodulation of the immune
response mediated by Plasmodium (Cunnington, 2012), and also
due to the bouts of high fever.
Although there are some disagreements, the evidence indi-
cates that the effects of fever are complex but overall beneficial.
Studies have demonstrated that the increased temperature dur-
ing fever assists healing directly (by physico–chemical activities)
and indirectly because it leads to the enhancements of several
immunological processes (El-Radhi, 2012). Fever exerts an over-
all adverse effect on the growth of bacteria and the replication
of viruses. Temperatures >37◦C restrict a wide range of Gram-
negative bacteria (Green and Vermeulen, 1994), and frequent
administration of antipyretics to patients with bacterial diseases
can worsen their illness (El-Radhi, 2012). The elevated tem-
perature prevents the bacteria from synthesizing the protective
lipopolysaccharides that are the major component of the outer
membrane of Gram-negative bacteria (Green and Vermeulen,
1994). Lipopolysaccharides contribute greatly to the structural
integrity of the bacteria and protect the membrane from certain
types of chemical attack. Moreover, in the past, malarial fever was
the principal form of treatment for neurological syphilis. It is now
proven that its effectiveness was principally due to the “physi-
cal” increase in temperature (Snounou and Pérignon, 2013). In
addition, most viruses cease to replicate at temperatures between
40 and 42◦C (El-Radhi, 2012). Almost all infectious diseases can
cause fever, but inmalarial endemic areas, only malaria frequently
induces high fevers that are able to directly and indirectly reduce
the deleterious effects of some other infections on a fairly reg-
ular basis. In contrast, malarial fever can also exacerbate viral
infections; herpesviruses, for example, respond to an increase
of temperature with rapid reactivation and active viral gene
transcription of latent virus (Grinde, 2013). Moreover, despite
the temperature sensitivities of various Gram-negative bacteria
species, malaria exacerbates their infections in individuals, sug-
gesting that during malarial disease, the deleterious effects on the
immune response far outweigh the salutary effects of fever, e.g.,
malarial infections are associated with increase of Gram-negative
bacteremia (Cunnington and Riley, 2012).
An improved understanding of the interactions between plas-
modia, other pathogens and human hosts is necessary, par-
ticularly for viral co-infections, as there is a paucity of data,
and for malarial and helminthic co-infections, as some anti-
inflammatory profiles are associated with protection, while others
are not (Frosch and John, 2012). Further studies are also needed
to reveal the temporal and life history-associated stage-specific
differences in immune responsiveness (Jackson et al., 2011), and
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to delineate the modulations of the immune response according
to the stages of the disease (chronic or acute, and asymptomatic
or symptomatic), the levels of superinfection and reinfection
and the malarial endemic rate (which may be correlated with
premunition level: after repeated bouts of malaria that occur
over a relatively short period of time, an individual develops a
non-sterilizing immunity that does not prevent parasites from
developing and circulating in the blood after a new inoculation
but does generally suppress the development of severe clinical
symptoms; Russell et al., 1963). Possible cytokine modulations
during periods of fits with fever also need to be analyzed. A
deeper mechanistic and clinical understanding of the effects of
co-infection on immunity, and especially on the immunomod-
ulation induced by Plasmodium, would help the development of
efficient vaccines.
The possible consequences of co-infections must also greatly
depend on the genotypes of human hosts and pathogens. Malaria
infections often involve more than one genotype per species
(Mobegi et al., 2012), which has also been commonly observed
with many other host parasites (Read and Taylor, 2001; Balmer
and Tanner, 2011; Alizon et al., 2013). In their review, Balmer
and Tanner (2011) discussed previous theoretical and experimen-
tal studies suggesting that mixed infections have broad ranges
of clinically relevant effects and involve a number of human
infectious agents. These effects include alterations in the host
immune response and changes in pathogen and disease dynam-
ics caused by interactions between Plasmodium strains, many
of which can lead to pathogen evolution. Although the cause
of infection by multiple distinct strains is considered to be an
important epidemiological parameter for malaria (Doolan et al.,
2009), it remains a neglected aspect that is just beginning to
be considered for other diseases (Balmer and Tanner, 2011).
However, the differences between co-infections caused by dif-
ferent strains of the same species or by different species have
been recently discussed in a study reporting the difficulties in
evaluating multiple infections by similar strains of the same
species (Alizon et al., 2013). Considering the genotypes of par-
asites involved in co-infections may help to reconcile some of
the apparent contradictions in the literature. Moreover, most
studies have concentrated their efforts on P. falciparum or the
murine model of malaria, so to date, data concerning other
human Plasmodium species are either completely lacking or insuf-
ficient to allow any firm conclusions (Cunnington and Riley,
2010). Studies of the relationships between P. vivax malaria and
other diseases are particularly important to this understanding
due to the pathogenicity and endemicity of this species (Baird,
2013).
Two or more types of parasite strains or species infecting an
individual host may interact directly by physical (as fever) or by
chemical means, and indirectly via “bottom-up” processes (e.g.,
competition for shared host resources) or “top-down” processes
(e.g., facilitation or immune-mediated competition) (Haydon
et al., 2003). However, these last authors have stressed the dif-
ficulty of disentangling the “bottom-up” and “top-down” pro-
cesses. Recently, Griffiths et al. (2014) have analyzed over 300
published studies to construct a network outlining the manner by
which groups of co-infecting parasites tend to interact, suggesting
that pairs of parasite species are most likely to interact indirectly
through shared resources, rather than through immune responses
or other parasites. The majority of malaria infections consist of
multiple competing genotypes and/or Plasmodium species, and
resource-mediated (e.g., red blood cells), immune-mediated, or
potentially, interference competition between strains results in
the suppressions of parasite densities (Mideo, 2009; Pollitt et al.,
2011). However, although red blood cell density has been shown
to affect malaria intensity in laboratory mice and in humans,
suggesting competition between Plasmodium strains and species
(Antia et al., 2008), many of the studies mentioned here high-
light the role of immune modulation or of fever in governing
the interactions between Plasmodium and other infectious agents.
Moreover, hemotrophic parasites other than plasmodia (such as
protozoa belonging to the class piroplasmidea and bacteria, such
as Bartonella spp. and Mycoplasma spp.) relatively rarely affect
humans, and thus, direct competition with plasmodia rarely
occurs. Parasites causing hemorrhaging and anemia can impact
the age profiles of the red blood cells available for plasmodia (neg-
atively or positively). The case of Plasmodium/HBV co-infection
is particularly interesting because interactions between these two
parasites may be both direct, involving competition for the same
attachment sites on hepatic cells, and indirect, via the host’s
immune system, which has antagonistic consequences (Freimanis
et al., 2012). As already suggested by Kochin et al. (2010) fur-
ther studies are required to determine the respective impacts of
innate immunity and resource limitation on the control malaria
infections.
Despite the very limited medical knowledge available over
2000 years, ancient authors were aware of the often deleteri-
ous consequences of co-infections on human populations, and
they have also cited examples of the supposed antagonistic inter-
actions between concurrent diseases (Sallares, 2002). Although
critical analyses of these earlier works are not easy because of
the limited diagnostic tools and the ambiguity of the terms
used, the analyses of these early reports may provide very rele-
vant information regarding past pathocoenoses and the evolution
of medical thought. In addition, contradictions with current
knowledge may lead to the testing of new hypotheses that may
produce valuable data; for example, the examination of the puta-
tive deleterious relationship between malaria and plague. The
exacerbation of Gram-positive bacterial infections by malaria
is currently well-known and also involves Yersinia enterocolit-
ica (Scott et al., 2011), which belongs to the same genus as
the plague agent. There are difficulties in identifying diseases
involved in historical pathocoenoses, given the frequent ambigu-
ity or vagueness of descriptions of diseases in historical sources.
Various types of pathogens frequently infected individuals, even
if one of them could be dominant, and the very wide variety of
symptoms make their etiologies difficult to pinpoint. In addition,
malaria’s role as an important component of the pathocoenoses
could make difficult to determinate the nature of causal agents.
First, malaria has protean manifestations, and misdiagnosis can
be very common. Second, malaria may be incorrectly dismissed as
a diagnosis when intermittent fevers did not occur due e.g., to co-
infections. Third, the complex patterns of relationships between
malaria and other diseases render retrodiagnosis difficult or even
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impossible. Fortunately, current developments in technology pro-
vide retrospectively “proof” thanks to DNA analyses. Indeed, as
for other infectious diseases, direct evidence for malaria can come
from the detection of specific DNA sequences in the remains.
The DNA of P. falciparum has been retrieved from both skele-
tal remains (Sallares and Gomzi, 2001) and the soft tissues of
Egyptian mummies (e.g., Hawass et al., 2010). The successful
amplification of ancient plasmodia DNA suggests a massive infec-
tion, as a low level of parasitemia would likely go undetected
after so much time had passed (Sallares et al., 2004). Despite
its longer persistence in the human body, the amplification of
ancient DNA is more difficult for P. vivax than for P. falciparum
(Pinello, 2008). In the future, the continual improvement of tech-
niques should not only yield estimates of the relative proportions
of each parasite species in an area and for a given period but also
should indicate the potential virulence of the latter. Moreover,
studies of ancient DNA could yield data regarding the different
constituents of past pathocoenoses in malaria-endemic regions.
Research on plasmodia DNA constitutes an indispensable prelim-
inary to any study on this topic, as in a recent study that revealed
malaria (P. falciparum) and tuberculosis co-infections in mum-
mies from Ancient Egypt (Lalremruata et al., 2013). In addition,
future research should explore the role of the ancient spread of
alleles in conferring resistance. The findings would aid our under-
standing of the interrelations between the human genome and
pathogens over recent millennia and could allow us to date the
appearances of these mutations.
To conclude, the improved understanding of the prevalence
of co-infection is greatly needed, in part because co-infections—
including those with malaria—are often associated with worse
host health symptoms and higher parasite abundances com-
pared with hosts with single infections, and they are associated
with reduced treatment efficacies and increased treatment costs
(Griffiths et al., 2014). Moreover, co-infections are concentrated
among the impoverished populations living in developing coun-
tries where health needs are the greatest (Bonds et al., 2010).
In addition, examples such as the malaria-syphilis comorbidity,
highlight the fact that the simplistic black-and-white, manichean
perception of the parasite world is partially erroneous. Malaria
could not be (always) the quintessence of evil.
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